Claudine Vermot Desroches
About
Claudine Vermot Desroches is from Illkirch-Graffenstaden, Grand Est, France. Claudine works in the following industries: "Pharmaceutical Manufacturing". Claudine is currently Research Director Immuno - Oncology at DOMAIN Therapeutics, located in Strasbourg, Grand Est, France. Claudine also works as Expert in Translational Research for Human Health, Immunotherapies and Life Sciences at TheraWings Consulting , a job Claudine has held since Jan 2018. In Claudine's previous role as a Co-founder, Chief Scientific Officer, Board member at IDD Biotech SA, Claudine worked in Lyon Area, France until Nov 2017. Prior to joining IDD Biotech SA, Claudine was a Research Director at EUSA Pharma / OPi and held the position of Research Director at Lyon area -,France. Prior to that, Claudine was a R&D Director at Diaclone, based in Besançon Area, France from Jan 1992 to Dec 2003.
You can find Claudine Vermot Desroches's email at finalscout.com. FinalScout is a professional database with business professional profiles and company profiles.
Claudine Vermot Desroches's current jobs
Domain Therapeutics discovers Drugs that target GPCRs to cure Cancer. Domain Therapeutics is a preclinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. Domain Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The company Domain Therapeutics is headquartered in Illkirch, France with research centers in Illkirch, France and Montreal, Canada.
A translational research consulting company dedicated on the discovery and development of innovative medicines for Pharmaceutical, Biotech or Start-up companies Therapeutic area : Immunology, Oncology, Immuno-Oncology, Onco-Metabolism, Inflammation, Auto-immunity, Transplantation Topics - Therapeutic product development including preclinical, bioprocess and manufacturing - Target identification and validation, Drug discovery, Drug repurposing, Bioassays set up - Immunotherapies (NCE, NBE) - Antibody, Oncolytic virus, Immunocheckpoint, Tumor microenvironment, Cell therapies… - Therapeutic lead design, Target Product Profile (TTP) - Concept identification, Preclinical experimental program design, Results analysis - Mode of actions & Drug bioprocess development & IND review - Intellectual property & Freedom to Operate
Claudine Vermot Desroches's past jobs
R&D of innovative immunotherapies in oncology - «Science today, Medicine tomorrow» Key achievement : license agreement with Genmab / IDD004 / Hexaduobody MAb anti DR5 Assignments - Innovation strategy identification, target identification and mAb design selection - Design and implementation of R&D projects related to therapeutic monoclonal antibodies - Steering and coordination of R&D projects - Management of cross-disciplinary laboratory based teams - Leadership of partnerships with public / private laboratories - Design and writing of patents, publications, congress - Biotech company organization & global management - Reporting to strategic / executive / boards
Assignments : Design and implementation of R&D projects related to therapeutic monoclonal antibodies Key achievements : License Agreement with GSK pharmaceutical company for a fully human anti-IL6 - Conception & orientation of scientific programs - Monitoring of academic/industrial partnerships - R&D team management and student trainings (PhD, Master) - Scientific communication (internal, external, reports and publications) - Transverse contribution to bioprocess, preclinical or clinical development - Project leader in partnership with Vaccinex (USA)
Assignments : Development of a library of murine MAbs, from the target identification to MAb application for research, diagnostic or therapeutic use